(Q40242928)

18 September 2017

1 reference

title

Short-course therapy for tuberculosis (English)

1 reference

18 September 2017

1 reference

M Aquinas

1

1 reference

18 September 2017

1 August 1982

1 reference

18 September 2017

1 reference

18 September 2017

24

1 reference

18 September 2017

2

1 reference

18 September 2017

118-132

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198224020-00002

18 September 2017

0 references

cites work

Controlled trial of four thrice-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis

1 reference

12 December 2020

Results at 5 years of a controlled comparison of a 6-month and a standard 18-month regimen of chemotherapy for pulmonary tuberculosis

1 reference

12 December 2020

Two three-month treatment regimens for pulmonary tuberculosis

1 reference

12 December 2020

Sputum-smear-negative pulmonary tuberculosis: controlled trial of 3-month and 2-month regimens of chemotherapy

1 reference

12 December 2020

A controlled trial of six months chemotherapy in pulmonary tuberculosis. First Report: results during chemotherapy. British Thoracic Association

1 reference

12 December 2020

Tuberculosis chemotherapy practices in major metropolitan health departments in the United States

1 reference

12 December 2020

Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Third report. East African-British Medical Research Councils

1 reference

12 December 2020

Rifampin in initial treatment of pulmonary tuberculosis. A.U.S. Public Health Service tuberculosis therapy trial

1 reference

12 December 2020

A service program of antituberculosis chemotherapy with five drugs for four months in the treatment of drug addicts and prisoners with pulmonary tuberculosis in Hong Kong. Hong Kong Chest Service/British Medical Research Council

1 reference

12 December 2020

Transmission of tubercle bacilli: The effects of chemotherapy

1 reference

12 December 2020

Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis

1 reference

12 December 2020

Observations in vitro on the suitability of pyrazinamide for intermittent chemotherapy of tuberculosis

1 reference

12 December 2020

A controlled clinical trial of the role of thiacetazone-containing regimens in the treatment of pulmonary tuberculosis in Singapore. Singapore Tuberculosis Services-Brompton Hospital-British Medical Research Council Investigation

1 reference

12 December 2020

Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. Second report of the 4th study. East African/British Medical Research Councils Study

1 reference

12 December 2020

Short-course chemotherapy for pulmonary tuberculosis

1 reference

12 December 2020

The nature of man and physician

1 reference

12 December 2020

Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis: first report: Third East African/British Medical Research Councils study

1 reference

12 December 2020

Controlled trial of 6-month and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong. The results up to 30 months

1 reference

12 December 2020

Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis

1 reference

12 December 2020

Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association

1 reference

12 December 2020

Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis: The results up to 24 months

1 reference

12 December 2020

A controlled comparison of a twice-weekly and three once-weekly regimens in the initial treatment of pulmonary tuberculosis

1 reference

12 December 2020

10.2165/00003495-198224020-00002

Identifiers

DOI

1 reference

PubMed ID

6749471

Dimensions Publication ID

18 September 2017

0 references

1 reference

PubMed ID

6749471